What is the current ivd immunodiagnostic raw material market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the ivd immunodiagnostic raw material market?

Increasing demand for diagnostic tests and technological advancements drive the market.

What are the major challenges facing the ivd immunodiagnostic raw material market?

Stringent regulations and high development costs are significant challenges.

Which regions are the leaders in the ivd immunodiagnostic raw material market?

North America and Europe are the leading regions due to high demand.

Who are the top companies in the ivd immunodiagnostic raw material market?

Major players include Roche, Abbott, and Siemens Healthineers.

What are the future opportunities in the ivd immunodiagnostic raw material market?

Emerging markets and point-of-care diagnostics offer significant growth opportunities.

How does technology impact the ivd immunodiagnostic raw material market?

Advances in technology improve test accuracy and efficiency.

What is the regulatory landscape for the ivd immunodiagnostic raw material market?

Regulations vary by region, with FDA and CE marking being notable examples.

What is the future outlook for the ivd immunodiagnostic raw material market size?

The market is expected to reach USD 2.5 billion by 2033.

ivd immunodiagnostic raw material Expansion Opportunities & Forecast Analysis 2033

ivd immunodiagnostic raw material by Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Test, Autoimmune Disease, Other), by Types (Core Reaction System, Signal System, Carrier, Reaction Environment), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $4800 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $4800 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

ivd immunodiagnostic raw material Market Size | CAGR 12.3 Forecast 2033

ivd immunodiagnostic raw material Expansion Opportunities & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $4800 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $4800 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

ivd immunodiagnostic raw material Market Overview

The IVD immunodiagnostic raw material market refers to the industry that provides essential components for in-vitro diagnostic tests. As a crucial segment of the healthcare industry, the IVD immunodiagnostic raw material market size is estimated to be around $14.5 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2026-2033. This industry expansion can be attributed to the increasing demand for diagnostic tests, driven by the rising prevalence of chronic diseases and the growing need for early disease detection. The scope of this market encompasses a range of products, including antibodies, antigens, and other reagents, which are used in various applications such as clinical chemistry, molecular diagnostics, and immunohistochemistry.

Loading chart…

The IVD immunodiagnostic raw material market is driven by several key forces, including technology shifts towards automated and point-of-care testing, regulations such as the European Union's In Vitro Diagnostic Regulation (IVDR), and consumer behavior driven by the increasing awareness of preventive healthcare. The largest region in this market is North America, accounting for approximately 40% of the global market share, while the fastest-growing region is Asia-Pacific, driven by the rapid expansion of the healthcare industry in countries such as China and India. Overall, the IVD immunodiagnostic raw material market is expected to experience significant growth in the coming years, driven by the increasing demand for diagnostic tests and the expanding range of applications for these products.

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 billion
Revenue forecast in 2033	12.14 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; BBI Solutions; ThermoFisher; Meridian Bioscience; Roche; HyTest; Abbott; JSR; Danaher; Vircell; Toyobo; Medix Biochemica; Autobio Diagnostics; Maccura Biotechnology; Fapon Biotech; Vazyme; Suzhou Nanomicro Technology; Genzyme; BioVentix; Microbix; Abcam; Fitzgerald Industries International; Institut Virion-Serion Gmbh
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The ivd immunodiagnostic raw material market is experiencing significant shifts, driven by various factors that impact its growth forecast. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Advancements in immunodiagnostic technologies are increasing the demand for high-quality raw materials, thereby driving the ivd immunodiagnostic raw material market size.

Government initiatives and investments in healthcare infrastructure are boosting the adoption of ivd immunodiagnostic tests, leading to a surge in the demand for raw materials.

Restraints2 items

Stringent regulatory requirements for the approval and use of ivd immunodiagnostic raw materials can hinder market growth by increasing costs and complexity for manufacturers.

Fluctuations in the global supply chain of raw materials can impact the growth forecast of the ivd immunodiagnostic raw material market, making it challenging for companies to maintain a stable supply.

Opportunities2 items

The increasing prevalence of chronic diseases and infectious diseases is creating new opportunities for the ivd immunodiagnostic raw material market, as the demand for diagnostic tests rises.

Emerging markets in Asia and Latin America offer significant growth potential for ivd immunodiagnostic raw material suppliers, driven by improving healthcare infrastructure and increasing demand for diagnostic services.

Challenges2 items

The ivd immunodiagnostic raw material market faces challenges related to the high cost of research and development, which can limit the entry of new players and hinder innovation.

Ensuring the quality and consistency of raw materials is a significant challenge, as it directly impacts the accuracy and reliability of ivd immunodiagnostic tests, affecting the overall market growth and reputation.

Market Segmentation

Loading chart…

The Application segment of the ivd immunodiagnostic raw material market plays a crucial role in determining the overall market size. This segment is divided into subtypes, including infectious diseases, oncology, and endocrinology, among others. Each subtype contributes significantly to the market size, with infectious diseases holding the largest share due to the increasing prevalence of infectious diseases worldwide. Understanding the ivd immunodiagnostic raw material segmentation is essential to identifying the key areas of growth and development in the market.

The Types segment of the ivd immunodiagnostic raw material market is another critical aspect of the market taxonomy. This segment includes subtypes such as antibodies, antigens, and enzymes, among others. Antibodies are the most widely used type, accounting for the largest share of the market. The demand for high-quality antibodies is driving the growth of this segment, with manufacturers focusing on developing innovative products to meet the increasing demand. Analyzing the market taxonomy and ivd immunodiagnostic raw material market trends is vital to understanding the dynamics of the Types segment.

ivd immunodiagnostic raw material Segmentation Breakdown13 items

Application

Therapeutic Drug Monitoring

Oncology

Cardiology

Endocrinology

Infectious Disease Test

Autoimmune Disease

Other

Types

Core Reaction System

Signal System

Carrier

Reaction Environment

Regional Insights

Loading chart…

The ivd immunodiagnostic raw material market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and the fastest-growing region, driven by increasing adoption of ivd immunodiagnostic technologies. Key drivers for Asia Pacific include government policies supporting the development of the healthcare industry, significant investments in research and development, and a large and growing demographics. In contrast, North America and Europe are expected to experience steady growth, driven by established infrastructure and mature ecosystem.

In North America, key drivers include a well-established ecosystem, high adoption rates of ivd immunodiagnostic technologies, and significant investments in research and development. Europe is driven by a strong infrastructure, favorable policies, and a large demographics. Latin America and Middle East & Africa are expected to experience slower growth, due to limited infrastructure and lower adoption rates, but are still expected to contribute to the overall ivd immunodiagnostic raw material market growth.

Regional Key Drivers5 items

Asia Pacific: government policies, investments in research and development, large demographics

North America: established ecosystem, high adoption rates, significant investments

Europe: strong infrastructure, favorable policies, large demographics

Latin America: limited infrastructure, lower adoption rates

Middle East & Africa: limited infrastructure, lower adoption rates

Competitive Landscape

The ivd immunodiagnostic raw material market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The ivd immunodiagnostic raw material competitive landscape is characterized by high competition, with companies employing various strategies to gain market share. Key competitive levers include product innovation, distribution networks, and regulatory compliance.

Companies in this market employ strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. Competitive differentiation is achieved through technology, service models, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To address these challenges, companies focus on strategic initiatives, including:

Merck: regional expansion

ThermoFisher: innovation pipeline

Roche: premium pricing

HyTest: OEM tie-ups

Abbott: local manufacturing

Danaher: vertical integration

Key ivd immunodiagnostic raw material Companies23 items

Merck

BBI Solutions

ThermoFisher

Meridian Bioscience

Roche

HyTest

Abbott

JSR

Danaher

Vircell

Toyobo

Medix Biochemica

Autobio Diagnostics

Maccura Biotechnology

Fapon Biotech

Vazyme

Suzhou Nanomicro Technology

Genzyme

BioVentix

Microbix

Abcam

Fitzgerald Industries International

Institut Virion-Serion Gmbh

Market Ecosystem

The ivd immunodiagnostic raw material ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of raw materials and components used in immunodiagnostic devices. The ecosystem involves a complex interplay of various stakeholders, each contributing to the production and delivery of these essential materials.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and manufacture immunodiagnostic devices

Technology providers — develop and license core technologies

System integrators / EPCs — integrate raw materials into finished devices

Distributors / channel partners — manage logistics and distribution

Regulators/standards bodies — establish and enforce industry standards

End users / buyers — purchase and utilize immunodiagnostic devices

The flow of value within the ivd immunodiagnostic raw material ecosystem is influenced by control points, such as regulatory approvals and industry standards, which can create bottlenecks and impact the adoption of new materials and technologies. Dependency risks, including input constraints and supply chain disruptions, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can limit the flexibility of stakeholders to change suppliers or technologies. As the ecosystem differs by region, due to varying regulatory environments and market demands, stakeholders must navigate these complexities to ensure a stable and efficient supply of high-quality raw materials.

Recent Industry Insights

The ivd immunodiagnostic raw material industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed, such as collaborations between leading diagnostic companies and research institutions, to advance the development of innovative immunodiagnostic solutions. Furthermore, the industry has seen a surge in mergers and acquisitions, with major players expanding their product portfolios and strengthening their market presence. Recent product launches have also focused on improving assay sensitivity and specificity, driving growth in the iVD immunodiagnostic raw material industry.

Additionally, regulatory changes have been implemented to ensure the quality and safety of iVD products, while funding rounds have been secured by emerging companies to support the development of novel immunodiagnostic technologies. These advancements have contributed to a shift in consumer and enterprise trends, with an increased emphasis on personalized medicine and point-of-care diagnostics. As the iVD immunodiagnostic raw material industry continues to evolve, it is likely that we will see further innovation and consolidation, driving growth and transformation in the sector.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the ivd immunodiagnostic raw material market outlook is highly attractive, driven by increasing demand for diagnostic tests and advancements in technology. The competitive intensity is moderate, with key players focusing on innovation and strategic partnerships. The long-term outlook is positive, with opportunities for growth in emerging markets and the development of new diagnostic solutions.

The innovation landscape is rapidly evolving, with a focus on point-of-care diagnostics and molecular diagnostics. However, the demand-supply balance is a key risk factor, as supply chain disruptions can impact the availability of raw materials. Other risk factors include regulatory changes and intense competition, which can affect market dynamics. Overall, the market offers opportunities for growth and innovation, but players must navigate these challenges to succeed.

12 items

1. Executive Summary

2. ivd immunodiagnostic raw material Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global ivd immunodiagnostic raw material Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global ivd immunodiagnostic raw material Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global ivd immunodiagnostic raw material Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global ivd immunodiagnostic raw material Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global ivd immunodiagnostic raw material Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global ivd immunodiagnostic raw material Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global ivd immunodiagnostic raw material Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global ivd immunodiagnostic raw material Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global ivd immunodiagnostic raw material Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global ivd immunodiagnostic raw material Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global ivd immunodiagnostic raw material Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global ivd immunodiagnostic raw material Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global ivd immunodiagnostic raw material Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global ivd immunodiagnostic raw material Market Competition by Key Manufacturers

9.1. Global ivd immunodiagnostic raw material Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global ivd immunodiagnostic raw material: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Merck

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BBI Solutions

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ThermoFisher

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Meridian Bioscience

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Roche

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. HyTest

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Abbott

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. JSR

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Danaher

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Vircell

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Toyobo

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Medix Biochemica

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Autobio Diagnostics

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Maccura Biotechnology

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Fapon Biotech

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Vazyme

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Suzhou Nanomicro Technology

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Genzyme

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. BioVentix

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Microbix

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Abcam

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Fitzgerald Industries International

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Institut Virion-Serion Gmbh

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global ivd immunodiagnostic raw material Market

Figure 4: Global ivd immunodiagnostic raw material Market: Drivers

Figure 5: Global ivd immunodiagnostic raw material Market: Challenges

Figure 6: Global ivd immunodiagnostic raw material Market: Trends

Figure 7: Global ivd immunodiagnostic raw material Market: Opportunity

Figure 8: Global ivd immunodiagnostic raw material Market: Restraint

Figure 9: Global ivd immunodiagnostic raw material Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global ivd immunodiagnostic raw material Market Value (USD Million) By Region

Figure 19: Global ivd immunodiagnostic raw material Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global ivd immunodiagnostic raw material Market Value (USD Million) By Region

Figure 27: Global ivd immunodiagnostic raw material Market Share (%) By: Regions (2032)

Figure 28: Global ivd immunodiagnostic raw material Market Volume (K) By Region

Figure 29: Global ivd immunodiagnostic raw material Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global ivd immunodiagnostic raw material Market Value (USD Million) By Region

Figure 37: Global ivd immunodiagnostic raw material Market Share (%) By: Regions (2032)

Figure 38: Global ivd immunodiagnostic raw material Market Volume (K) By Region

Figure 39: Global ivd immunodiagnostic raw material Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

141 items

Table 1: Market Segmentation Analysis

Table 2: Global ivd immunodiagnostic raw material Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global ivd immunodiagnostic raw material Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global ivd immunodiagnostic raw material Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global ivd immunodiagnostic raw material Market Value (USD Million) By Region

Table 14: Global ivd immunodiagnostic raw material Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global ivd immunodiagnostic raw material Market Volume (K) By Region

Table 31: Global ivd immunodiagnostic raw material Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global ivd immunodiagnostic raw material Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global ivd immunodiagnostic raw material Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global ivd immunodiagnostic raw material Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Merck Basic Information And Sales Area

Table 52: Merck. Products Portfolio

Table 53: BBI Solutions Basic Information And Sales Area

Table 54: BBI Solutions. Products Portfolio

Table 55: ThermoFisher Basic Information And Sales Area

Table 56: ThermoFisher. Products Portfolio

Table 57: Meridian Bioscience Basic Information And Sales Area

Table 58: Meridian Bioscience. Products Portfolio

Table 59: Roche Basic Information And Sales Area

Table 60: Roche. Products Portfolio

Table 61: HyTest Basic Information And Sales Area

Table 62: HyTest. Products Portfolio

Table 63: Abbott Basic Information And Sales Area

Table 64: Abbott. Products Portfolio

Table 65: JSR Basic Information And Sales Area

Table 66: JSR. Products Portfolio

Table 67: Danaher Basic Information And Sales Area

Table 68: Danaher. Products Portfolio

Table 69: Vircell Basic Information And Sales Area

Table 70: Vircell. Products Portfolio

Table 71: Toyobo Basic Information And Sales Area

Table 72: Toyobo. Products Portfolio

Table 73: Medix Biochemica Basic Information And Sales Area

Table 74: Medix Biochemica. Products Portfolio

Table 75: Autobio Diagnostics Basic Information And Sales Area

Table 76: Autobio Diagnostics. Products Portfolio

Table 77: Maccura Biotechnology Basic Information And Sales Area

Table 78: Maccura Biotechnology. Products Portfolio

Table 79: Fapon Biotech Basic Information And Sales Area

Table 80: Fapon Biotech. Products Portfolio

Table 81: Vazyme Basic Information And Sales Area

Table 82: Vazyme. Products Portfolio

Table 83: Suzhou Nanomicro Technology Basic Information And Sales Area

Table 84: Suzhou Nanomicro Technology. Products Portfolio

Table 85: Genzyme Basic Information And Sales Area

Table 86: Genzyme. Products Portfolio

Table 87: BioVentix Basic Information And Sales Area

Table 88: BioVentix. Products Portfolio

Table 89: Microbix Basic Information And Sales Area

Table 90: Microbix. Products Portfolio

Table 91: Abcam Basic Information And Sales Area

Table 92: Abcam. Products Portfolio

Table 93: Fitzgerald Industries International Basic Information And Sales Area

Table 94: Fitzgerald Industries International. Products Portfolio

Table 95: Institut Virion-Serion Gmbh Basic Information And Sales Area

Table 96: Institut Virion-Serion Gmbh. Products Portfolio

Table 97: Global Market Value (USD Million) (2025-2032) By Application

Table 98: Global Market Share (%) By Application (2032)

Table 99: Global Market Value (USD Million) (2025-2032) By Types

Table 100: Global Market Share (%) By Types (2032)

Table 101: Global Market Volume (K) (2025-2032) By Application

Table 102: Global Market Share (%) By Application (2032)

Table 103: Global Market Volume (K) (2025-2032) By Types

Table 104: Global Market Share (%) By Types (2032)

Table 105: Global ivd immunodiagnostic raw material Market Value (USD Million) By Region

Table 106: Global ivd immunodiagnostic raw material Market Share (%) By Region (2025-2032)

Table 107: North America Market Value (USD Million) (2025-2032) By Country

Table 108: North America Market Value (USD Million) (2025-2032) By Application

Table 109: North America Market Value (USD Million) (2025-2032) By Types

Table 110: Europe Market Value (USD Million) (2025-2032) By Country

Table 111: Europe Market Value (USD Million) (2025-2032) By Application

Table 112: Europe Market Value (USD Million) (2025-2032) By Types

Table 113: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 114: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 115: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 116: South America Market Value (USD Million) (2025-2032) By Country

Table 117: South America Market Value (USD Million) (2025-2032) By Application

Table 118: South America Market Value (USD Million) (2025-2032) By Types

Table 119: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 120: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 121: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 122: Global ivd immunodiagnostic raw material Market Volume (K) By Region

Table 123: Global ivd immunodiagnostic raw material Market Share (%) By Region (2025-2032)

Table 124: North America Market Volume (K) (2025-2032) By Country

Table 125: North America Market Volume (K) (2025-2032) By Application

Table 126: North America Market Volume (K) (2025-2032) By Types

Table 127: Europe Market Volume (K) (2025-2032) By Country

Table 128: Europe Market Volume (K) (2025-2032) By Application

Table 129: Europe Market Volume (K) (2025-2032) By Types

Table 130: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 131: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 132: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 133: South America Market Volume (K) (2025-2032) By Country

Table 134: South America Market Volume (K) (2025-2032) By Application

Table 135: South America Market Volume (K) (2025-2032) By Types

Table 136: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 137: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 138: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 139: Research Programs/Design For This Report

Table 140: Key Data Information From Secondary Sources

Table 141: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

ivd immunodiagnostic raw material Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 billion
Revenue forecast in 2033	12.14 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; BBI Solutions; ThermoFisher; Meridian Bioscience; Roche; HyTest; Abbott; JSR; Danaher; Vircell; Toyobo; Medix Biochemica; Autobio Diagnostics; Maccura Biotechnology; Fapon Biotech; Vazyme; Suzhou Nanomicro Technology; Genzyme; BioVentix; Microbix; Abcam; Fitzgerald Industries International; Institut Virion-Serion Gmbh
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options